81 related articles for article (PubMed ID: 12924042)
21. The potential influence of cell protectors for dose escalation in cancer therapy: an analysis of amifostine.
McCumber LM
Med Dosim; 2004; 29(2):139-43. PubMed ID: 15191764
[TBL] [Abstract][Full Text] [Related]
22. TCP and NTCP: a basic introduction.
Baumann M; Petersen C
Rays; 2005; 30(2):99-104. PubMed ID: 16294901
[TBL] [Abstract][Full Text] [Related]
23. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
Palm A; Johansson KA
Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
[TBL] [Abstract][Full Text] [Related]
24. Low-grade toxicity after conformal radiation therapy for prostate cancer--impact of bladder volume.
Pinkawa M; Fischedick K; Asadpour B; Gagel B; Piroth MD; Eble MJ
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(3):835-41. PubMed ID: 16289911
[TBL] [Abstract][Full Text] [Related]
25. Intensity-modulated vs. conformal radiotherapy of parotid gland tumors: potential impact on hearing loss.
Lamers-Kuijper E; Schwarz M; Rasch C; Mijnheer B
Med Dosim; 2007; 32(4):237-45. PubMed ID: 17980823
[TBL] [Abstract][Full Text] [Related]
26. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
27. Dosimetric and radiobiologic comparison of 3D conformal versus intensity modulated planning techniques for prostate bed radiotherapy.
Koontz BF; Das S; Temple K; Bynum S; Catalano S; Koontz JI; Montana GS; Oleson JR
Med Dosim; 2009; 34(3):256-60. PubMed ID: 19647638
[TBL] [Abstract][Full Text] [Related]
28. [Conformal radiotherapy for patients with clinical stage T1-T3 prostate cancer].
Majewski W; Miszczyk L; Zajusz A
Przegl Lek; 2004; 61(5):503-8. PubMed ID: 15515815
[TBL] [Abstract][Full Text] [Related]
29. Acute morbidity related to treatment volume during 3D-conformal radiation therapy for prostate cancer.
Karlsdóttir A; Johannessen DC; Muren LP; Wentzel-Larsen T; Dahl O
Radiother Oncol; 2004 Apr; 71(1):43-53. PubMed ID: 15066295
[TBL] [Abstract][Full Text] [Related]
30. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
Luxton G; Hancock SL; Boyer AL
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
[TBL] [Abstract][Full Text] [Related]
31. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial.
Koper PC; Jansen P; van Putten W; van Os M; Wijnmaalen AJ; Lebesque JV; Levendag PC
Radiother Oncol; 2004 Oct; 73(1):1-9. PubMed ID: 15465140
[TBL] [Abstract][Full Text] [Related]
32. Impact of volume and location of irradiated rectum wall on rectal blood loss after radiotherapy of prostate cancer.
Koper PC; Heemsbergen WD; Hoogeman MS; Jansen PP; Hart GA; Wijnmaalen AJ; van Os M; Boersma LJ; Lebesque JV; Levendag P
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1072-82. PubMed ID: 15001247
[TBL] [Abstract][Full Text] [Related]
33. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
34. Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol.
Carrie C; Muracciole X; Gomez F; Habrand JL; Benhassel M; Mege M; Mahé M; Quetin P; Maire JP; Soum F; Baron MH; Clavere P; Chapet S; Gaci Z; Kolodie H; Maingon P; Vie B; Bernier V; Alapetite C; Hoffstetter S; Grill J; Lafay F;
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):711-6. PubMed ID: 15927408
[TBL] [Abstract][Full Text] [Related]
35. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
[TBL] [Abstract][Full Text] [Related]
36. A technique of partial breast irradiation utilizing proton beam radiotherapy: comparison with conformal x-ray therapy.
Bush DA; Slater JD; Garberoglio C; Yuh G; Hocko JM; Slater JM
Cancer J; 2007; 13(2):114-8. PubMed ID: 17476139
[TBL] [Abstract][Full Text] [Related]
37. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.
Weber DC; Lomax AJ; Rutz HP; Stadelmann O; Egger E; Timmermann B; Pedroni ES; Verwey J; Miralbell R; Goitein G;
Radiother Oncol; 2004 Jun; 71(3):251-8. PubMed ID: 15172139
[TBL] [Abstract][Full Text] [Related]
38. Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams.
Noël G; Feuvret L; Calugaru V; Dhermain F; Mammar H; Haie-Méder C; Ponvert D; Hasboun D; Ferrand R; Nauraye C; Boisserie G; Beaudré A; Gaboriaud G; Mazal A; Habrand JL; Mazeron JJ
Acta Oncol; 2005; 44(7):700-8. PubMed ID: 16227160
[TBL] [Abstract][Full Text] [Related]
39. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
[TBL] [Abstract][Full Text] [Related]
40. Impact of dose and volume on subcutaneous fibrosis.
De Santis M; Luzi S; Errico A; Frascino V; Mangiacotti MG; Picardi V; Morganti AG
Rays; 2005; 30(2):169-73. PubMed ID: 16294910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]